Clinical Trial Update: Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis [Phase 1]

View source ↗

Summary

Recruitment is ongoing for a Phase 1 trial evaluating Relmacabtagene Autoleucel for systemic sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Relmacabtagene Autoleucel (relmacabtagene autoleucel)

Snippet

Sponsor: Liangjing Lu | Conditions: Systemic Sclerosis | Phase 1 | Status: RECRUITING